TipRanks
Advertisement
Advertisement

DE:OCD1 Stock Latest News

Niagen Bioscience launches ‘Don’t Get Old. Age Better.’ campaign
The FlyNiagen Bioscience launches ‘Don’t Get Old. Age Better.’ campaign
3d ago
NAGE
Niagen Bioscience enters start-up agreement with Mass General Brigham
PremiumThe Fly
Niagen Bioscience enters start-up agreement with Mass General Brigham
4d ago
NAGE
Niagen Bioscience announces publication of preclinical study on CD38
PremiumThe Fly
Niagen Bioscience announces publication of preclinical study on CD38
13d ago
NAGE
Niagen Bioscience subsidiary engaged Red Sky Partners to support NB4168
PremiumThe Fly
Niagen Bioscience subsidiary engaged Red Sky Partners to support NB4168
17d ago
NAGE
Niagen Bioscience expands Tru Niagen footprint with GNC, Sam’s Club
PremiumThe Fly
Niagen Bioscience expands Tru Niagen footprint with GNC, Sam’s Club
2M ago
WMT
NAGE
Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
PremiumThe FlyMeet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
2M ago
EL
Niagen CFO says core business ‘cash flow positive with no dilution risk’
Premium
The Fly
Niagen CFO says core business ‘cash flow positive with no dilution risk’
2M ago
NAGE
Skincare business has ‘significant upside potential,’ Niagen CFO tells The Fly
Premium
The Fly
Skincare business has ‘significant upside potential,’ Niagen CFO tells The Fly
2M ago
NAGE
Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’
PremiumThe Fly
Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’
2M ago
NAGE
Niagen Bioscience announces Tru Niagen is now available at Walmart
PremiumThe Fly
Niagen Bioscience announces Tru Niagen is now available at Walmart
2M ago
WMT
NAGE
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
PremiumCompany Announcements
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
2M ago
NAGE
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
PremiumThe Fly
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
2M ago
NAGE
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
PremiumRatingsAnalyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
2M ago
NAGE
Niagen Bioscience Reports Strong Q2 Results, Highlights Growth
Premium
Company Announcements
Niagen Bioscience Reports Strong Q2 Results, Highlights Growth
2M ago
8K
NAGE
Niagen Bioscience sees ecommerce business growing 10%-15% in FY26
Premium
The Fly
Niagen Bioscience sees ecommerce business growing 10%-15% in FY26
2M ago
NAGE
Niagen Bioscience reports Q2 EPS 1c vs 4c last year
PremiumThe Fly
Niagen Bioscience reports Q2 EPS 1c vs 4c last year
2M ago
NAGE
Niagen Bioscience selects Evotec to advance development for NB4168
PremiumThe Fly
Niagen Bioscience selects Evotec to advance development for NB4168
2M ago
EVO
NAGE
NAGE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NAGE Upcoming Earnings Report: What to Expect?
2M ago
NAGE
Niagen Bioscience announces publication on muscle epigenetic age
PremiumThe Fly
Niagen Bioscience announces publication on muscle epigenetic age
2M ago
NAGE
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
PremiumThe FlyNiagen Bioscience price target lowered to $11 from $12 at Ladenburg
3M ago
NAGE
Niagen Bioscience appoints Kale as Senior Director of Global External Research
Premium
The Fly
Niagen Bioscience appoints Kale as Senior Director of Global External Research
3M ago
NAGE
Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168
Premium
The Fly
Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168
3M ago
NAGE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >